Chronic mucocutaneous candidiasis: immunologic and antibiotic therapy.
D000328:Adult; D000367:Age Factors; D000666:Amphotericin B / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002179:Candidiasis, Cutaneous / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D003881:Dermatomycoses / Q000150:complications; D005260:Female; D005533:Foot Dermatoses / Q000628:therapy; D005667:Furunculosis / Q000150:complications; D006229:Hand Dermatoses / Q000628:therapy; D006562:Herpes Zoster / Q000150:complications; D006801:Humans; D007111:Immunity, Cellular; D007112:Immunity, Maternally-Acquired; D007167:Immunotherapy; D007223:Infant; D008297:Male; D011014:Pneumonia / Q000150:complications; D011704:Pyelonephritis / Q000150:complications; D012075:Remission, Spontaneous; D012882:Skin Tests; D013203:Staphylococcal Infections / Q000150:complications
D000900:Anti-Bacterial Agents; D000666:Amphotericin B